Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000243782 | SCV000307958 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000243782 | SCV000344362 | likely benign | not specified | 2016-08-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001705355 | SCV000519428 | benign | not provided | 2019-12-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000526421 | SCV000651048 | benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001705355 | SCV002545561 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | FLNC: BP4, BP7, BS1 |
Ambry Genetics | RCV002338800 | SCV002642584 | likely benign | Cardiovascular phenotype | 2018-12-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002487123 | SCV002794555 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26 | 2021-09-22 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000243782 | SCV004038052 | benign | not specified | 2023-08-19 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003486789 | SCV004240651 | benign | Cardiomyopathy | 2022-11-30 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001705355 | SCV005221606 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV000243782 | SCV001923605 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000243782 | SCV001929770 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000243782 | SCV001957567 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000243782 | SCV001970487 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001705355 | SCV002035593 | likely benign | not provided | no assertion criteria provided | clinical testing |